Velocity
This Week's Stories
Eucalyptus

Eucalyptus

Telehealth · Digital Health · Weight Loss

Acquisition

Hims & Hers to acquire Eucalyptus for up to $1.15B in cash-and-stock deal

July 23, 2026

Deal Value

$1.1B

The startup becomes its acquirer's global arm, landing just as the buyer battles Novo Nordisk over a pulled copycat weight-loss pill.

  • Hims & Hers Health agreed to acquire Australian digital health company Eucalyptus in a deal valued at up to $1.15 billion, announced Thursday.
  • Eucalyptus runs consumer telehealth brands including weight-loss program Juniper and men's health service Pilot, which together serve over 775,000 customers.
  • Only $240 million of the price will be paid in cash at closing, with the remainder structured as stock and performance-based incentives tied to future results.
  • The acquisition gives Hims & Hers a foothold in Australia and Japan and strengthens its position in the UK, Germany and Canada, with Eucalyptus becoming its international division.
  • The deal comes as Hims & Hers fights a lawsuit from Novo Nordisk after being forced to pull its $49 compounded copy of the weight-loss drug Wegovy under FDA pressure.
  • The deal shows telehealth players using international M&A to diversify revenue and offset regulatory risk at home, accelerating consolidation in weight-loss and wellness care.

Get the app

Stay Ahead With Velocity

Deep company profiles, investor context, and every original source behind this story — plus the next one, the moment it breaks.

Download on the App StoreGet it on Google Play

More This Week

View All →